MedPath
NMPA Approval

Nusinersen Sodium Injection

国药准字HJ20190032

January 15, 2024

H20190032

Drug Information

诺西那生钠注射液

注射剂

5ml:12mg(按诺西那生计)

化学药品

January 15, 2024

January 14, 2029

Company Information

Applicant Company

Prins Mauritslaan 13,1171 LP Badhoevedorp, The Netherlands

Manufacturing Company

PATHEON ITALIA SPA

2 Trav.SX.Via Morolense,5,Ferentino 03013,Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

诺西那生钠注射液 - NMPA 批准文号 | MedPath